Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. - Jahn N; Jahn E; Saadati M; Bullinger L; Larson RA; Ottone T; Amadori S; Prior TW; Brandwein JM; Appelbaum FR; Medeiros BC; Tallman MS; et al. (Leukemia, 2022)